Table 1.
Clinicopathological characteristics of patient samples and expression of ZAP in bladder cancer patients and correlation between ZAP expression and Clinicopathological characteristics of bladder cancer patients
| Characteristics | Total (n=90) | ZAP expression | Chi-square test p-value | ||
|---|---|---|---|---|---|
| Low expression (45.6%) | Normal expression (54.4%) | ||||
| Gender | Female | 14 | 5 (35.7%) | 9 (64.3%) | 0.421 |
| Male | 76 | 36 (47.4%) | 40 (52.6%) | ||
| Age (years) | ≤70 | 48 | 21 (43.8%) | 27 (56.2%) | 0.7131 |
| >70 | 42 | 20 (47.6%) | 22 (52.4%) | ||
| Anatomic stage | 0is | 5 | 1 (20.0%) | 4 (80.0%) | 0.0037 |
| I | 6 | 1 (16.7%) | 5 (83.3%) | ||
| II | 24 | 5 (20.8%) | 19 (79.2%) | ||
| III | 37 | 24 (64.9%) | 13 (35.1%) | ||
| IV | 18 | 10 (55.6%) | 8 (44.4%) | ||
| T classification | Tis | 5 | 1 (20.0%) | 4 (80.0%) | 0.0024 |
| T1 | 9 | 1 (11.1%) | 8 (88.9%) | ||
| T2 | 24 | 6 (25.0%) | 18 (75.0%) | ||
| T3 | 43 | 27 (62.8%) | 16 (37.2%) | ||
| T4 | 9 | 6 (66.7%) | 3 (33.3%) | ||
| Node invasion | No | 72 | 31 (43.1%) | 41 (56.9%) | 0.3409 |
| Yes | 18 | 10 (55.6%) | 8 (44.4%) | ||